Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00441155
Status:
COMPLETED
Last Update Posted:
2013-05-13
First Post:
2007-02-26
Brief Title:
Patients Completing Core Protocol CAMN107A2103 Exhibiting Stable Disease SD Partial Response PR or Complete Response CR to Nilotinib in Combination With Imatinib
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis